非标准的因子VIIa结合模式揭示了素类蛋白质酶中的S1口袋可塑性
Laura Tesmer1,2, Hans Matter2, Otmar Klingler3
1Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.
ChemMedChem
|January 31, 2026
概括
在抗血栓治疗中寻求FVIIa抑制剂. 一个新的晶体结构揭示了一个重建的活性部位和崩的S1口袋,这表明了FVIIa和相关的血清蛋白酶的新抑制策略.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 因子VIIa (FVIIa) 是血液凝固中的一个关键酶.
- 由于潜在的广泛治疗窗口,FVIIa抑制剂是有吸引力的药物标.
- 现有的FVIIa抑制剂面临挑战,主要是口服生物可用性差.
研究的目的:
- 介绍FVIIa-组织因子复合物的新型X射线晶体结构与结合抑制剂.
- 调查FVIIa活性部位的结构可塑性,特别是S1口袋.
- 探索抑制FVIIa和其他血清蛋白酶的新策略.
主要方法:
- 在1.9 Å分辨率的X射线晶体学FVIIa-组织因子复合物与基于氧沙的抑制剂.
- 原子学分子动力学模拟 (总共0.17毫秒).
- 分析FVIIa和其他血清酸酶S1囊中的构造转换.
主要成果:
- 晶体结构显示了一个广泛重建的活性部位和在抑制剂结合时崩的S1口袋.
- 分子动力学模拟显示,在FVIIa.中,在开放和缩的S1口袋状态之间存在着构造过渡.
- 在16个研究的血清酶中,12个观察到类似的S1口袋可塑性.
结论:
- FVIIa表现出S1口袋可塑性,存在于开放和崩状态之间的平衡状态.
- 这种可塑性为开发新型FVIIa抑制剂提供了基础.
- 这些发现表明,一种可通用的方法可以抑制其他血清蛋白酶.
相关概念视频
Free Energy Changes for Nonstandard States
13.6K
The free energy change for a process taking place with reactants and products present under nonstandard conditions (pressures other than 1 bar; concentrations other than 1 M) is related to the standard free energy change according to this equation:
13.6K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
485
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485
Factors Affecting Protein-Drug Binding: Patient-Related Factors
324
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324
Factors Affecting Protein-Drug Binding: Protein-Related Factors
558
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
558
Factors Affecting Protein-Drug Binding: Drug Interactions
605
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
605
What is a Mode?
26.0K
The mode is one of the commonly used measures of a central tendency. It is defined as the most frequent value in a data set.
There can be more than one mode in a data set if multiple values have the same highest frequency. For instance, suppose that the Statistics exam scores of 20 students are: 50; 53; 59; 59; 63; 63; 72; 72; 72; 72; 72; 76; 78; 81; 83; 84; 84; 84; 90; 93. Here, the mode is 72, as it occurs most frequently, five times.
A data set with two modes is called bimodal. For example,...
There can be more than one mode in a data set if multiple values have the same highest frequency. For instance, suppose that the Statistics exam scores of 20 students are: 50; 53; 59; 59; 63; 63; 72; 72; 72; 72; 72; 76; 78; 81; 83; 84; 84; 84; 90; 93. Here, the mode is 72, as it occurs most frequently, five times.
A data set with two modes is called bimodal. For example,...
26.0K


